YD Bio (NASDAQ:YDES) Share Price Crosses Below Two Hundred Day Moving Average – Here’s What Happened

YD Bio Limited (NASDAQ:YDES) shares crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $5.34 and traded as low as $5.11. YD Bio shares last traded at $5.20, with a volume of 79,311 shares traded.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of YD Bio to a “hold” rating in a research note on Saturday, September 26th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

YD Bio Trading Down 15.4%

The business’s 50 day moving average is $5.49 and its 200 day moving average is $5.34.

YD Bio (NASDAQ:YDES) last issued its quarterly earnings results on Tuesday, September 1st. The biotechnology company reported $0.05 EPS for the quarter. The firm had revenue of $0.42 million for the quarter.

Institutional Inflows and Outflows

A hedge fund recently raised its position in YD Bio stock. Cypress Capital Management LLC WY grew its holdings in shares of YD Bio Limited (NASDAQ:YDES) by 9.8% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 33,690 shares of the biotechnology company’s stock after buying an additional 3,000 shares during the quarter. Cypress Capital Management LLC WY’s holdings in YD Bio were worth $76,000 at the end of the most recent reporting period.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.